Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sara Tomei, Ena Wang, Lucia Gemma Delogu, Francesco M Marincola & Davide Bedognetti. (2014) Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma. Expert Opinion on Biological Therapy 14:5, pages 663-686.
Read now
Read now
Alexei Shimanovsky & Constantin A Dasanu. (2014) Updates on immunotherapy in non-small cell lung cancer. Expert Opinion on Biological Therapy 14:4, pages 411-418.
Read now
Read now
Articles from other publishers (14)
Meredith K. Chuk, Jennie T. Chang, Marc R. Theoret, Emmanuel Sampene, Kun He, Shawna L. Weis, Whitney S. Helms, Runyan Jin, Hongshan Li, Jingyu Yu, Hong Zhao, Liang Zhao, Mark Paciga, Deborah Schmiel, Rashmi Rawat, Patricia Keegan & Richard Pazdur. (2017) FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma. Clinical Cancer Research 23:19, pages 5666-5670.
Crossref
Crossref
Katarina M. Mirjačić Martinović, Nada Lj. Babović, Radan R. Džodić, Vladimir B. Jurišić, Aleksandra Z. Ninković & Gordana M. Konjević. (2016) Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels. Melanoma Research 26:6, pages 551-564.
Crossref
Crossref
Maggie L. Diller, Ragini R. Kudchadkar, Keith A. Delman, David H. Lawson & Mandy L. Ford. (2016) Exogenous IL-2 Induces FoxP3+ Th17 Cells In Vivo in Melanoma Patients. Journal of Immunotherapy 39:9, pages 355-366.
Crossref
Crossref
Krisztina Buzás, Annamária Marton, Csaba Vizler, Edina Gyukity-Sebestyén, Mária Harmati, Katalin Nagy, Ágnes Zvara, Róbert L. Katona, Vilmos Tubak, Valéria Endrész, István B. Németh, Judit Oláh, László Vígh, Tamás Bíró & Lajos Kemény. (2016) Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression. Journal of Investigative Dermatology 136:4, pages 862-865.
Crossref
Crossref
Manfred Schartl, Yingjia Shen, Katja Maurus, Ron Walter, Chad Tomlinson, Richard K. Wilson, John Postlethwait & Wesley C. Warren. (2015) Whole Body Melanoma Transcriptome Response in Medaka. PLOS ONE 10:12, pages e0143057.
Crossref
Crossref
Shaojuan Yu, Fuli Wang, Li Fan, Yuying Wei, Haitao Li, Yuanjie Sun, Angang Yang, Boquan Jin, Chaojun Song & Kun Yang. (2015) BAP31, a promising target for the immunotherapy of malignant melanomas. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Katarina Mirjačić Martinović, Nada Babović, Radan Džodić, Vladimir Jurišić, Suzana Matković & Gordana Konjević. (2015) Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients. Journal of Translational Medicine 13:1.
Crossref
Crossref
Claudio Tabolacci, Martina Cordella, Lorenzo Turcano, Stefania Rossi, Alessandro Lentini, Sabrina Mariotti, Roberto Nisini, Giovanni Sette, Adriana Eramo, Lucia Piredda, Ruggero De Maria, Francesco Facchiano & Simone Beninati. (2015) Aloe-emodin exerts a potent anticancer and immunomodulatory activity on BRAF-mutated human melanoma cells. European Journal of Pharmacology 762, pages 283-292.
Crossref
Crossref
Monika Håkerud, Pål K. Selbo, Ying Waeckerle-Men, Emmanuel Contassot, Piotr Dziunycz, Thomas M. Kündig, Anders Høgset & Pål Johansen. (2015) Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells. Journal of Controlled Release 198, pages 10-17.
Crossref
Crossref
Renato Santos de Oliveira Filho, Daniel Arcuschin de Oliveira, Vitor Augusto Melão Martinho, Célia Beatriz Gianotti Antoneli, Ludmilla Altino de Lima Marcussi & Carlos Eduardo dos Santos Ferreira. (2014) Serum level of vitamin D3 in cutaneous melanoma. Einstein (São Paulo) 12:4, pages 473-476.
Crossref
Crossref
Kristina M. Ilieva, Isabel Correa, Debra H. Josephs, Panagiotis Karagiannis, Isioma U. Egbuniwe, Michiala J. Cafferkey, James F. Spicer, Mark Harries, Frank O. Nestle, Katie E. Lacy & Sophia N. Karagiannis. (2014)
Effects of
BRAF
Mutations and
BRAF
Inhibition on Immune Responses to Melanoma
. Molecular Cancer Therapeutics 13:12, pages 2769-2783.
Crossref
Crossref
SADEK MALAS, MICAELA HARRASSER, KATIE E. LACY & SOPHIA N. KARAGIANNIS. (2014) Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review). Oncology Reports 32:3, pages 875-886.
Crossref
Crossref
Darren M. Palathinkal, Timmie R. Sharma, Henry B. Koon & Jeremy S. Bordeaux. (2014) Current Systemic Therapies for Melanoma. Dermatologic Surgery 40:9, pages 948-963.
Crossref
Crossref
Benjamin Lebwohl, Hanna Eriksson, Johan Hansson, Peter H.R. Green & Jonas F. Ludvigsson. (2014) Risk of cutaneous malignant melanoma in patients with celiac disease: A population-based study. Journal of the American Academy of Dermatology 71:2, pages 245-248.
Crossref
Crossref